Vital Therapies Stock Price, Forecast & Analysis (NASDAQ:VTL) Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Vital Therapies Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range$0.83MA: $8.88▼$14.5052-Week Range N/AVolumeN/AAverage Volume21.62 million shsMarket Capitalization$35.17 millionP/E RatioN/ADividend YieldN/ABeta3.51 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Vital Therapies, Inc, a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc in June 2003. Vital Therapies, Inc was founded in 2003 and is based in San Diego, California. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:VTL Previous Symbol CUSIPN/A CIK1280776 Webhttp://vitaltherapies.com/ Phone858-673-6840Debt Debt-to-Equity RatioN/A Current Ratio6.97 Quick Ratio6.97Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.29 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net Income$-41,470,000.00 Net MarginsN/A Return on Equity-235.33% Return on Assets-182.35%Miscellaneous Employees10 Outstanding Shares42,370,000Market Cap$35.17 million Next Earnings DateN/A OptionableOptionable Receive VTL News and Ratings via Email Sign-up to receive the latest news and ratings for VTL and its competitors with MarketBeat's FREE daily newsletter. Vital Therapies (NASDAQ:VTL) Frequently Asked Questions What is Vital Therapies' stock symbol? Vital Therapies trades on the NASDAQ under the ticker symbol "VTL." How were Vital Therapies' earnings last quarter? Vital Therapies (NASDAQ:VTL) announced its quarterly earnings data on Tuesday, August, 7th. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.03. View Vital Therapies' Earnings History. Has Vital Therapies been receiving favorable news coverage? News headlines about VTL stock have trended very negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vital Therapies earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Vital Therapies. Who are some of Vital Therapies' key competitors? Some companies that are related to Vital Therapies include Arcturus Therapeutics (ARCT), Obseva (OBSV), Aquestive Therapeutics (AQST), Axovant Gene Therapies (AXGT), MEI Pharma (MEIP), Tyme Technologies (TYME), Paratek Pharmaceuticals (PRTK), Northwest Biotherapeutics (NWBO), Abeona Therapeutics (ABEO), Agile Therapeutics (AGRX), Menlo Therapeutics (MNLO), CytoDyn (CYDY), Harrow Health (HROW), Correvio Pharma (CORV) and Newron Pharmaceuticals (NWPHF). What other stocks do shareholders of Vital Therapies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vital Therapies investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Stanley Black & Decker (SWK), Innerscope Hearing Technologies (INND), Anthera Pharmaceuticals (ANTH), Micron Technology (MU), Novavax (NVAX), ACADIA Pharmaceuticals (ACAD) and Synergy Pharmaceuticals (SGYP). Who are Vital Therapies' key executives? Vital Therapies' management team includes the folowing people: Dr. Duane D. Nash M.B.A., M.D., J.D., M.B.A, CEO, Pres & Director (Age 48)Mr. Robert A. Ashley, Exec. VP & Chief Scientific Officer (Age 61)Mr. Michael V. Swanson M.B.A., M.B.A, Exec. VP, CFO & Treasurer (Age 64)Mr. John M. Dunn, Gen. Counsel & Sec. (Age 67) How big of a company is Vital Therapies? Vital Therapies has a market capitalization of $0.00. Vital Therapies employs 10 workers across the globe.View Additional Information About Vital Therapies. What is Vital Therapies' official website? The official website for Vital Therapies is http://vitaltherapies.com/. How can I contact Vital Therapies? Vital Therapies' mailing address is 15222-B AVENUE OF SCIENCE, SAN DIEGO CA, 92128. The company can be reached via phone at 858-673-6840 or via email at [email protected] MarketBeat Community Rating for Vital Therapies (NASDAQ VTL)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 325 (Vote Outperform)Underperform Votes: 238 (Vote Underperform)Total Votes: 563MarketBeat's community ratings are surveys of what our community members think about Vital Therapies and other stocks. Vote "Outperform" if you believe VTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VTL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/12/2019 by MarketBeat.com StaffFeatured Article: What is the QQQ ETF?